Pandion Therapeutics Inc (PAND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -38,105 | -21,877 | -10,887 |
| Depreciation Amortization | 512 | 242 | 94 |
| Accounts receivable | 85 | -1,035 | N/A |
| Accounts payable and accrued liabilities | 492 | 358 | 548 |
| Other Working Capital | -160 | 8,179 | 136 |
| Other Operating Activity | 2,188 | 704 | -496 |
| Operating Cash Flow | $-34,988 | $-13,429 | $-10,605 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2,788 | -635 | -637 |
| Investing Cash Flow | $-2,788 | $-635 | $-637 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 6,000 | 2,000 | 2,000 |
| Debt Repayment | -2,000 | N/A | N/A |
| Common Stock Issued | 138,626 | N/A | 13 |
| Other Financing Activity | 99,573 | 17,862 | 18,933 |
| Financing Cash Flow | $242,199 | $19,862 | $20,946 |
| Beginning Cash Position | 15,970 | 10,172 | 468 |
| End Cash Position | 220,393 | 15,970 | 10,172 |
| Net Cash Flow | $204,423 | $5,798 | $9,704 |
| Free Cash Flow | |||
| Operating Cash Flow | -34,988 | -13,429 | -10,605 |
| Capital Expenditure | -2,788 | -635 | -637 |
| Free Cash Flow | -37,776 | -14,064 | -11,242 |